A broad effect of ocrelizumab on the peripheral immune component in patients with early relapsing-remitting multiple sclerosis

被引：0
作者：
Garcia, A. [1 ]
Morille, J. [1 ]
Shah, S. [1 ]
Le Frere, F. [2 ]
Nicot, A. [1 ]
Berthelot, L. [1 ]
Wiertlewski, S. [1 ,2 ]
Gourraud, P. -A. [1 ,3 ]
Raposo, C. [4 ]
Bakdache, F. [4 ]
Buffels, R. [4 ]
Laplaud, D. -A. [1 ,2 ]
机构：
[1] Univ Nantes, CHU Nantes, INSERM, Ctr Rech Transplantat & Immunol,UMR 1064, Nantes, France
[2] CHU Nantes, Dept Neurol, CIC Neurol, Nantes, France
[3] CHU Nantes, INSERM, CIC 1413, Pole Hosp Univ 11 Sante Publ,Clin Donnees,ATIP Av, Nantes, France
[4] F Hoffmann La Roche Ltd, Basel, Switzerland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P701
引用
收藏
页码：593 / 594
页数：2
相关论文
共 50 条
[41]   Comorbidity in in patients with relapsing-remitting multiple sclerosis. [J].
Somilo, O., V ;
Makarov, S. O. ;
Kalbus, O., I .
MEDICNI PERSPEKTIVI, 2024, 29 (03) :137-143
[42]   Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis (vol 15, 1480676, 2024) [J].
Rodriguez-Jorge, Fernando ;
Fernandez-Velasco, Jose Ignacio ;
Villarrubia, Noelia ;
Gracia-Gil, Julia ;
Fernandez, Eva ;
Meca-Lallana, Virginia ;
Diaz-Perez, Carolina ;
de la Maza, Susana Sainz ;
Pacheco, Eva Maria ;
Quiroga, Ana ;
Ramio-Torrenta, Lluis ;
Martinez-Yelamos, Sergio ;
Bau, Laura ;
Monreal, Enric ;
Lopez-Real, Ana ;
Rodero-Romero, Alexander ;
Borrega, Laura ;
Diaz, Santiago ;
Eguia, Pablo ;
Espino, Mercedes ;
Chico-Garcia, Juan Luis ;
Barrero, Francisco Javier ;
Martinez-Gines, Maria Luisa ;
Garcia-Dominguez, Jose Manuel ;
de la Fuente, Soraya ;
Moreno, Irene ;
Sainz-Amo, Raquel ;
Mane-Martinez, M. Alba ;
Caminero, Ana ;
Castellanos-Pinedo, Fernando ;
Lopez, Ana Gomez ;
Labiano-Fontcuberta, Andres ;
Ayuso, Lucia ;
Abreu, Rossana ;
Hernandez, Miguel angel ;
Meca-Lallana, Jose ;
Martin-Aguilar, Lorena ;
Garcia, Alfonso Muriel ;
Masjuan, Jaime ;
Costa-Frossard, Lucienne ;
Villar, Luisa Maria .
FRONTIERS IN IMMUNOLOGY, 2024, 15
[43]   Rapid onset of ocrelizumab suppression of brain MRI activity in relapsing-remitting multiple sclerosis [J].
Barkhof, Frederik ;
Kappos, Ludwig ;
Bar-Or, Amit ;
Li, David ;
Belachew, Shibeshih ;
Julian, Laura ;
Sauter, Annette ;
Stokmaier, Daniela ;
Hauser, Stephen L. .
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) :NP14-NP15
[44]   The incidence of infusion associated reactions in Ocrelizumab-treated Relapsing-Remitting Multiple Sclerosis patients. [J].
Bewick, C. ;
Das, E. ;
Collins, J. ;
Nash, C. ;
Fisniku, L. .
EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 :684-684
[45]   Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis [J].
Nocentini, U ;
Pasqualetti, P ;
Bonavita, S ;
Buccafusca, M ;
De Caro, MF ;
Farina, D ;
Girlanda, P ;
Le Pira, F ;
Lugaresi, A ;
Quattrone, A ;
Reggio, A ;
Salemi, G ;
Savettieri, G ;
Tedeschi, G ;
Trojano, M ;
Valentino, P ;
Caltagirone, C .
MULTIPLE SCLEROSIS, 2006, 12 (01) :77-87
[46]   Prevalence of Depression in Patients with Relapsing-remitting Multiple Sclerosis [J].
Iranmanesh, F. .
MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (04) :523-523
[47]   Subclinical atherosclerosis in patients with relapsing-remitting multiple sclerosis [J].
Tomaž Omerzu ;
Jožef Magdič ;
Radovan Hojs ;
Uroš Potočnik ;
Mario Gorenjak ;
Tanja Hojs Fabjan .
Wiener klinische Wochenschrift, 2024, 136 :40-47
[48]   Teriflunomide in Patients with Relapsing-Remitting Forms of Multiple Sclerosis [J].
Chan, Andrew ;
de Seze, Jerome ;
Comabella, Manuel .
CNS DRUGS, 2016, 30 (01) :41-51
[49]   Cognitive resiliency in relapsing-remitting multiple sclerosis patients [J].
Harel, Y. ;
Achiron, A. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 :S212-S212
[50]   Cardiovascular abnormalities in patients with relapsing-remitting multiple sclerosis [J].
El-Ghoneimy, Lobna Ahmed Talaat ;
Shalaby, Nevin ;
Elmazny, Alaa ;
El-Baghdady, Yasser ;
Shehata, Hatem .
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) :NP3-NP3
12345